+218.1%
MRNA vs P
+197.6%
+20.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | P | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.9% | -1.5% | -3.2% |
| 7D | -12.1% | +11.6% | -23.7% | -13.4% |
| 30D | -1.3% | -23.7% | +22.4% | +1.7% |
| 3M | +250.9% | -8.0% | +258.9% | +251.9% |
| 6M | +343.0% | +27.9% | +315.1% | +316.1% |
| YTD | +657.4% | +61.2% | +596.3% | +577.1% |
| 1Y | +794.9% | +28.6% | +766.3% | +716.4% |
| 3Y | +218.1% | +200.5% | +17.7% | +151.3% |
| All | +218.1% | +197.6% | +20.6% | +151.3% |
Cumulative growth
Daily Returns
Daily percentage return beside P.
Daily Out/Under-Performance
Portfolio return minus P return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × P return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded P wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling